Aagami has been chosen by an Indian company, a first win. It has been appointed by an Indian company for Out Licensing their innovatively develo...
Published : 07 Jan 2014
Read MoreIn January 2014, Dinesh Jain, CEO of Aagami a will attend J P Morgan Healthcare conference and Biotech Showcase conference respectively. Like man...
Published : 20 Dec 2013
Read MoreBangalore, India and Freising, Germany, December 17, 2013 Pieris AG, a next generation therapeutic protein R&D Company, and Stelis Bioph...
Published : 17 Dec 2013
Read MoreWith 2 new client wins from Europe, Aagami gears up to bring them success in their India Initiatives.Riding high on bringing another success to a clie...
Published : 01 Nov 2013
Read More--cMet antagonist, PRS-110, to be the flagship program--October 16, 2013 Freising, Germany; Naperville, USA: Pieris AG, a next generation therape...
Published : 16 Oct 2013
Read MoreWe are pleased to announce that Aagami has moved to a new office located at:Aagami, Inc.2135 City Gate Lane, Suite 300Naperville IL 60563Phone: +1-630...
Published : 02 Sep 2013
Read MoreAagami CEO Mr. Dinesh Jain, is attending BIOPHARM AMERICA 2013 in Boston between 17 and 20 September 2013.Aagami will be representing a host of ...
Published : 08 Aug 2013
Read MoreThe 2013 BIO International Convention, the global event of biotechnology, wrapped up 25 April, 2013 at McCormick Place in Chicago with a record number...
Published : 26 Apr 2013
Read MoreToday, a US Biotechnology company from Baton Rouge, Louisiana appointed Aagami for its out-licensing and partnering needs in India, and other emerging...
Published : 01 Mar 2013
Read MoreAagami, along with its Drug delivery technology Australian client, is on a deal making spree. After supporting deals with 3 Indians companies for this...
Published : 19 Jan 2013
Read More